Valeant planning to appoint a new CEO: CNBC, citing Dow Jones

January 5, 2016 11:25 PM

27 0

Valeant planning to appoint a new CEO: CNBC, citing Dow Jones

Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) is planning to appoint a new CEO as Chief Executive Michael Pearson remains hospitalized, CNBC tweeted, citing Dow Jones.

The new chief executive would replace the committee currently running the company, CNBC tweeted, citing Dow Jones. (bit.ly/1VGwoDe)

Also read: Exxon CEO is now Trump's secretary of state favorite -transition official

Read more

To category page

Loading...